It was great to speak to Dee & Warren about Nirtek and our technology. Nice touch from Dee to play "My Heart Will Go On" straight after the interview ❤️👍

JoVE Methods Collections help standardize techniques within research communities, so progress is made faster. A new collection guest-edited by @rubaiyea from @unimelb, titled "Experimental techniques in studying host restriction against viruses", is now accepting abstracts.

Interesting #Ethiopian photographs by Girma Berta collection NGV.

I've just joined the Australian and New Zealand Society for Immunology. Join me and many immunologists by becoming a member today! Great networking opportunities, access to Clinical & Translational Immunology and ICB - the journal and much more ctt.ec/fJEoY+ #ASImmuno #IAmAnImmunologist #Immunology

Congratulations Asmare Gelaw on your third year progress review. Have fun with the #writing 🤞

This is an amazing opportunity for Early stage investigators

What an opportunity! I wish I could postpone this position until I am done with my PhD.

The Kent lab is hiring! We're looking for a project manager to help co-ordinate our recently funded next-generation COVID-19 clinical vaccine development project 💉 doherty.edu.au/news-events/ne… More information and application below 👇 jobs.unimelb.edu.au/caw/en/job/906…

I presented my PhD oration today. Thank you everyone for joining me 🙏

Congratulations Svenja Fritzlar

Today I get a nice birthday present from the Journal of Virology. We published part of my PhD work. We showed that Mouse Mx1 is antiviral against Herpes Simplex Virus Type 1. Check out below👇 journals.asm.org/doi/10.1128/jv…

Cameron/Arnold Lab at UNC is part of a national network contributing to pandemic preparedness. We are in need of colleagues. We can match your background and aspirations to a position from tech or postdoc to research assistant professor and more. If interested, email me your CV.

Check out our new paper published in Nature Communications on harnessing the power of mammalian immune proteins called guanylate-binding proteins as a new source of disease-fighting peptides.😊🔬 (1/4) nature.com/articles/s4146…

📣 Opportunity alert! Experienced in genomic surveillance and interested in helping inform public health policy? This collaborative role within our Department of Infectious Diseases could be for you! jobs.unimelb.edu.au/en/job/915377/… UniMelb MDHS The Royal Melbourne Hospital

I’m happy to share that I started a new position WHO CC Influenza Melbourne

WE ARE HIRING : Please follow this link for more details: melbournehealth.mercury.com.au/ViewPosition.a…

Mouse guanylate binding proteins of the chromosome 3 cluster (mGBPchr3) do not mediate potent antiviral activity against different human or mouse viruses in vitro and in vivo. From researchers University of Melbourne and Research at ANU including our EBM Si Ming Man doi.org/10.1038/s42003…

Pleased to share our paper nature.com/articles/s4200… mGBPs mediate defense against intracellular bacteria, but don't appear to be major component of antiviral immunity. The related GTPase mMx proteins on the other hand, are potent mediator of intracellular defense against viruses.